Twelve metabolites of the synthetic cannabinoid, EAM-2201, had been tentatively discovered in human hepatocytes in vitro, and in human liver and urine specimens in vivo for the first time. In vitro results point out that AM-2201 must be examined for prospective pharmacokinetic drug interactions in vivo as a result of https://eam220112086.blogadvize.com/38117142/the-basic-principles-of-mam-2201